Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
Base Year
Historical Year
Forecast Year
The global drug discovery and development solutions market is expected to grow at a CAGR of 13% in the forecast period of 2024-2032.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The global market for drug discovery and development solutions is significantly aided by the industry growth in North America. The development of the drug discovery outsourcing industry in the region could be attributed to an increase in emphasis on discovering medicines for the treatment of COVID-19, which has resulted in drug discovery outsourcing to companies equipped with AI technology. In addition, the growth in the investment in research and development (R&D) by major pharmaceutical and biotechnology firms and their emphasis on streamlining the internal costs of drug discovery outsourcing is fuelling the growth of the drug discovery and development solutions industry.
Drug discovery refers to the discovery of new medication and to the process of creating a therapeutically active substance for a particular target molecule or pathway. Drug discovery comprises of screening hits, medicinal chemistry, and optimisation of hits to reduce possible side effects of drugs. The discovery and development solutions of drugs together is a full process of identifying and introducing a new medication in the market.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The service types in the market can be divided into the following:
The drug types in the market can be divided into small molecules and biologics. The process types can be segmented as:
The technology types in the industry can be segmented into the following:
Based on therapeutic area, the market can be segmented into:
The regional markets for drug discovery and development solutions can be divided into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The expansion of the demand for drug discovery outsourcing can be attributed to an increase in the emphasis on discovering medicines for the treatment of the rising COVID-19 pandemic, which has resulted in drug discovery outsourcing to companies equipped with AI technology. In addition, the growth in the investment in research and development (R&D) by major pharmaceutical and biotechnology firms and their emphasis on streamlining the internal costs of drug discovery outsourcing is fuelling the market growth. Developments in fundamental algorithms are used in computational information processing for predictive chemistry, which leads to improvements in scientific innovation and laboratory informatics. This is likely to increase the demand in the market in the coming years.
The report gives a detailed analysis of the following key players in the global drug discovery and development solutions market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:
The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.
REPORT FEATURES | DETAILS |
Base Year | 2023 |
Historical Period | 2017-2023 |
Forecast Period | 2024-2032 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Service Type |
|
Breakup by Drug Type |
|
Breakup by Process |
|
Breakup by Technology |
|
Breakup by Mode |
|
Breakup by Therapeutic Area |
|
Breakup by End Use |
|
Breakup by Region |
|
Market Dynamics |
|
Competitive Landscape |
|
Companies Covered |
|
Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
The market is projected to grow at a CAGR of 13% between 2024 and 2032.
The growth of the market is being driven by the growing population, expanding healthcare sector, increasing disposable incomes, and the thriving pharmaceuticals sector.
The increasing demand for outsourcing analytical testing services and growing research and development activities are the key trends guiding the growth of the market.
The major regions in the market are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
The different service types in the market are medicinal chemistry, biology services, drug metabolism, pharmaceutical services, and pharmacokinetics, among others.
The major drug types in the market are small molecules and biologics.
The significant processes in the market are target selection, target validation, hit-to-lead identification, lead optimisation, and candidate validation, among others.
The various technology types in the market are high throughput screening, biochips, pharmacogenetics, nanotechnology, and spectroscopy, among others.
The major therapeutic areas in the market are oncology, neurology, infectious and immune system diseases, digestive system diseases, and cardiovascular diseases, among others.
The major players in the global drug discovery and development solutions market are Abbott Laboratories Inc., AstraZeneca plc, Genentech, USA Inc, Charles River Laboratories International, Inc., Gilead Sciences, Inc., Pfizer Inc., Jubilant Biosys Ltd., Sanofi SA, and F. Hoffmann-La Roche Ltd, among others.
Purchase Full Report
Datasheet
Single User License
One User
Five User License
Five Users
Corporate License
Unlimited Users
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61 448 06 17 27
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63 287899028, +63 967 048 3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84865399124